Poseida Therapeutics, Inc.(PSTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PSTX Poseida Therapeutics, Inc.

停牌 05-09 08:02:28 EDT

9.50

+0.00

0.00%

最高9.50	最低9.50	成交量0.00
今开9.50	昨收9.50	日振幅0.00%
总市值9.29亿	流通市值5.92亿	总股本9,777万
成交额2.04亿	换手率0.00%	流通股本6,231万
市净率10.65	ROE-57.63%	每股收益-0.64
52周最高9.67	52周最低1.87	市盈率-14.95
股息0.00	股息收益率0.00	ROA-13.11%

北京优虎网络科技有限公司

{"stockData":{"symbol":"PSTX","market":"US","secType":"STK","nameCN":"Poseida Therapeutics, Inc.","latestPrice":9.5,"timestamp":1736283600000,"preClose":9.5,"halted":3,"volume":0,"delay":0,"floatShares":62312997,"shares":97774206,"eps":-0.635371,"marketStatus":"停牌","change":0,"latestTime":"05-09 08:02:25 EDT","open":9.5,"high":9.5,"low":9.5,"amount":204004526.1815905,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.635371,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746797400000},"marketStatusCode":1,"adr":0,"listingDate":1594353600000,"exchange":"NASDAQ","adjPreClose":9.5,"volumeRatio":0},"requestUrl":"/m/hq/s/PSTX","defaultTab":"news","newsList":[{"id":"2501145617","title":"罗氏将完成15亿美元收购美国生物制药公司Poseida","url":"https://stock-news.laohu8.com/highlight/detail?id=2501145617","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501145617?lang=zh_cn&edition=full","pubTime":"2025-01-08 15:52","pubTimestamp":1736322752,"startTime":"0","endTime":"0","summary":"据了解，Poseida专注于开发多种类型癌症的复杂免疫细胞疗法。罗氏表示，已接受支付Poseida近6500万股股份，相当于该公司股票的66%，股东以每股9美元的价格出价，并额外支付每股高达4美元的或有付款。罗氏称，在收购中，Poseida或罗氏不拥有的所有Poseida股份将转换为每股获得相同对价的权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010815573195fc8d21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010815573195fc8d21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","BK4139"],"gpt_icon":0},{"id":"2486588866","title":"Acurx Pharmaceuticals, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486588866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486588866?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:58","pubTimestamp":1732636693,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时58分，Acurx Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.30%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623581498e44b6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623581498e44b6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ACXP","BK4563","PSTX"],"gpt_icon":0},{"id":"2486688814","title":"Os Therapies Incorporated盘中异动 早盘快速下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486688814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486688814?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:56","pubTimestamp":1732636579,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时56分，Os Therapies Incorporated股票出现波动，股价快速跳水5.07%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Poseida Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Protagenic Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、木薯科学、Poseida Therapeutics, Inc.较为活跃，换手率分别为37.02%、24.94%、21.50%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.、Fate Therapeutics, Inc.，振幅分别为85.82%、42.94%、34.09%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623561998e44b69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623561998e44b69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","BK4139","OSTX"],"gpt_icon":0},{"id":"2486188864","title":"Biodexa Pharmaceuticals Plc盘中异动 早盘股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486188864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486188864?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:55","pubTimestamp":1732636520,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时55分，Biodexa Pharmaceuticals Plc股票出现异动，股价急速跳水5.80%。Biodexa Pharmaceuticals Plc股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Poseida Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Protagenic Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、木薯科学、Poseida Therapeutics, Inc.较为活跃，换手率分别为36.90%、24.82%、21.42%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.、Fate Therapeutics, Inc.，振幅分别为85.82%、42.94%、34.09%。Biodexa Pharmaceuticals Plc公司简介：Biodexa Pharmaceuticals PLC是一家药物输送技术公司，专注于改善药物的生物输送和生物分配。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126235520971a8ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126235520971a8ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDRX","BK4139","PSTX"],"gpt_icon":0},{"id":"2486027780","title":"万春医药盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486027780","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486027780?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:20","pubTimestamp":1732634417,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时20分，万春医药股票出现波动，股价大幅拉升5.08%。截至发稿，该股报1.86美元/股，成交量2834股，换手率0.01%，振幅5.65%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为0.37%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126232017abe0d488&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126232017abe0d488&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139","PSTX"],"gpt_icon":0},{"id":"1167973908","title":"异动解读 | 瑞士罗氏公司斥资15亿美元收购Poseida Therapeutics 公司股价飙升224.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167973908","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167973908?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:02","pubTimestamp":1732633358,"startTime":"0","endTime":"0","summary":"11月26日,在美国临床阶段生物制药公司Poseida Therapeutics Inc.盘中股价飙升224.65%,引发市场广泛关注。分析人士认为,此轮大涨的主因系瑞士制药巨头罗氏公司宣布将斥资15亿美元收购该公司所致。根据消息,罗氏计划以每股9美元的现金价格收购Poseida Therapeutics,使该公司的总股本价值达到10亿美元。自2022年起,Poseida Therapeutics就与罗氏开展合作,共同为血液系统恶性肿瘤患者开发即用型CAR-T细胞疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PSTX"],"gpt_icon":0},{"id":"2486004167","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘急速下跌5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486004167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486004167?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:47","pubTimestamp":1732632423,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时47分，Calidi Biotherapeutics, Inc.股票出现异动，股价急速下挫5.94%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126224703971a8a41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126224703971a8a41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","CLDI","BK4139"],"gpt_icon":0},{"id":"2486900141","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.13%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486900141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486900141?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:45","pubTimestamp":1732632336,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时45分，60 Degrees Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.13%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622453698e44acf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622453698e44acf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","SXTP","BK4007","BK4139"],"gpt_icon":0},{"id":"2486001230","title":"Poseida Therapeutics暴涨超223% 罗氏将以高达15亿美元收购该公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2486001230","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486001230?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:41","pubTimestamp":1732632115,"startTime":"0","endTime":"0","summary":"Poseida Therapeutics（PSTX.US）暴涨超223%，报9.25美元。消息面上，罗氏周二宣布，将以每股9美元的价格收购位于美国生物制药公司Poseida Therapeutics，收购完成后的总股本价值为10亿美元。如果达到特定里程碑，股东还将以每股4美元的不可交易的或有价值权（CVR），交易总价值高达约15亿美元。交易预计将于2025年第一季度完成。（格隆汇）\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"us","thumbnail":"http://n.sinaimg.cn/spider20241126/615/w350h265/20241126/9782-4570364278af48574299a49917c475ca.jpg","type":0,"news_type":0,"thumbnails":["http://n.sinaimg.cn/spider20241126/615/w350h265/20241126/9782-4570364278af48574299a49917c475ca.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-11-26/doc-incxmcyh4125363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["LENZ","PSTX","BK4139"],"gpt_icon":0},{"id":"2486001535","title":"Kodiak Sciences Inc盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486001535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486001535?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:38","pubTimestamp":1732631897,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时38分，Kodiak Sciences Inc股票出现异动，股价大幅下挫5.29%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Poseida Therapeutics, Inc.、Fate Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Oncternal Therapeutics, Inc.、Poseida Therapeutics, Inc.、木薯科学较为活跃，换手率分别为14.60%、12.02%、10.71%，振幅较大的相关个股有Cabaletta Bio, Inc.、Fate Therapeutics, Inc.、Caribou Biosciences, Inc.，振幅分别为19.65%、16.32%、15.35%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223817a25748ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223817a25748ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KOD","PSTX"],"gpt_icon":0},{"id":"2486004235","title":"Gt Biopharma, Inc.盘中异动 早盘急速上涨6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486004235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486004235?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:34","pubTimestamp":1732631645,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时34分，Gt Biopharma, Inc.股票出现异动，股价快速拉升6.42%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Poseida Therapeutics, Inc.、Fate Therapeutics, Inc.、Arrowhead Pharmaceuticals, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Poseida Therapeutics, Inc.、Cognition Therapeutics, Inc.较为活跃，换手率分别为13.86%、10.36%、8.59%，振幅较大的相关个股有Caribou Biosciences, Inc.、Cabaletta Bio, Inc.、Exicure, Inc.，振幅分别为13.61%、13.54%、12.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223405a2574684&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223405a2574684&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139","PSTX"],"gpt_icon":0},{"id":"2486700196","title":"Poseida Therapeutics, Inc.股价拉升224.57% 市值涨20.32亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486700196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486700196?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:31","pubTimestamp":1732631518,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时31分，Poseida Therapeutics, Inc.股票出现波动，股价急速上涨224.57%。Poseida Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。消息层面，截至22时31分，《罗氏15亿美元收购Poseida 预计明年一季度完成交易》资讯为影响Poseida Therapeutics, Inc.的重要信息。该信息摘要如下：临床阶段同种异体细胞治疗和基因药物领域的领先企业Poseida Therapeutics宣布将被罗氏控股以约15亿美元的总股权价值收购。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223201abe0bc96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223201abe0bc96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2486009035","title":"Alector, Inc.股价重挫34.60% 市值跌8776.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486009035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486009035?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:31","pubTimestamp":1732631503,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时31分，Alector, Inc.股票出现异动，股价快速下挫34.60%。截至发稿，该股报2.59美元/股，成交量95.769万股，换手率0.98%，振幅2.78%。Alector, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Poseida Therapeutics, Inc.、Arrowhead Pharmaceuticals, Inc.、Fate Therapeutics, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Citius Pharmaceuticals, Inc.、Poseida Therapeutics, Inc.较为活跃，换手率分别为13.16%、10.36%、9.81%，振幅较大的相关个股有Citius Pharmaceuticals, Inc.、Caribou Biosciences, Inc.、Fate Therapeutics, Inc.，振幅分别为17.33%、13.61%、11.78%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223143a2574521&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223143a2574521&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALEC","PSTX"],"gpt_icon":0},{"id":"2486001616","title":"Onconetix, Inc.盘中异动 早盘大幅上涨6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486001616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486001616?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:31","pubTimestamp":1732631474,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时31分，Onconetix, Inc.股票出现波动，股价大幅上涨6.17%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Poseida Therapeutics, Inc.、Caribou Biosciences, Inc.、Arrowhead Pharmaceuticals, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Citius Pharmaceuticals, Inc.、Poseida Therapeutics, Inc.较为活跃，换手率分别为13.01%、9.44%、9.33%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc.、Bioline Rx Ltd、Tectonic Therapeutic, Inc.，振幅分别为10.13%、7.62%、6.77%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223114971a89ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223114971a89ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO","PSTX"],"gpt_icon":0},{"id":"2486028030","title":"Traws Pharma, Inc.盘中异动 早盘股价大跌5.38%报4.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486028030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486028030?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:30","pubTimestamp":1732631447,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时30分，Traws Pharma, Inc.股票出现异动，股价快速下挫5.38%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Poseida Therapeutics, Inc.、Caribou Biosciences, Inc.、Arrowhead Pharmaceuticals, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Citius Pharmaceuticals, Inc.、Poseida Therapeutics, Inc.较为活跃，换手率分别为12.83%、9.40%、9.30%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc.、Bioline Rx Ltd、Inozyme Pharma, Inc.，振幅分别为9.38%、7.62%、4.73%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622304898e44a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622304898e44a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","BK4139","BK4007","TRAW"],"gpt_icon":0},{"id":"1169155813","title":"盘前 | Poseida Therapeutics、ZenaTech暴涨，英伟达升逾1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169155813","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169155813?lang=zh_cn&edition=full","pubTime":"2024-11-26 20:13","pubTimestamp":1732623207,"startTime":"0","endTime":"0","summary":"美股三大指数期货在盘前时段集体上涨。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZENA","NVDA","PSTX"],"gpt_icon":1},{"id":"2486269660","title":"美股异动｜罗氏将以高达15亿美元收购Poseida Therapeutics 后者盘前暴涨超217%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486269660","media":"港股那点事","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486269660?lang=zh_cn&edition=full","pubTime":"2024-11-26 17:10","pubTimestamp":1732612200,"startTime":"0","endTime":"0","summary":"Poseida Therapeutics(PSTX.US)盘前暴涨超217%，报9.07美元。消息面上，罗氏周二宣布，将以每股9美元的价格收购位于美国生物制药公司Poseida Therapeutics，收购完成后的总股本价值为10亿美元。如果达到特定里程碑，股东还将以每股4美元的不可交易的或有价值权(CVR)，交易总价值高达约15亿美元。交易预计将于2025年第一季度完成。(格隆汇)\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-11-26/doc-incxktkk7447196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LENZ","PSTX","BK4139"],"gpt_icon":0},{"id":"1116804004","title":"盘前异动 | Poseida Therapeutics暴涨，Rivian获多项利好，禾赛大涨13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116804004","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116804004?lang=zh_cn&edition=full","pubTime":"2024-11-26 17:06","pubTimestamp":1732611976,"startTime":"0","endTime":"0","summary":"美股三大指数期货在盘前时段小幅下跌。","market":"us","thumbnail":"https://community-static.tradeup.com/news/a177a34964d0e6d87a1fa00d94eaffea","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/a177a34964d0e6d87a1fa00d94eaffea"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSAI","PSTX","RIVN"],"gpt_icon":1},{"id":"2486025970","title":"罗氏(RHHBY)拟收购生物制药企业Poseida Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2486025970","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486025970?lang=zh_cn&edition=full","pubTime":"2024-11-26 16:57","pubTimestamp":1732611428,"startTime":"0","endTime":"0","summary":"金吾财讯 | 瑞士罗氏公司于本周二宣布，计划以每股9美元的价格收购位于加州的生物制药企业Poseida Therapeutics，收购完成后，该公司的总股本价值将达到10亿美元。此外，罗氏还提出，Poseida的股东将额外获得每股4美元的不可交易的或有价值权（CVR），使得此次交易的总价值最高可达约15亿美元。预计该交易将在2025年的第一季度内完成。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"282405","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","RHHBY","03165","BK4007","PSTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.poseida.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":2.0844},{"period":"1year","weight":2.5055},{"period":"ytd","weight":-0.0104}],"compareEarnings":[{"period":"1week","weight":0.0118},{"period":"1month","weight":0.1381},{"period":"3month","weight":-0.0594},{"period":"6month","weight":-0.0554},{"period":"1year","weight":0.0926},{"period":"ytd","weight":-0.0359}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Poseida Therapeutics, Inc.于2014年12月16日根据特拉华州法律注册成立。该公司是一家临床阶段的细胞和基因治疗公司，为癌症和罕见病患者推进一类新的治疗方法。该公司的专有基因工程技术用于创建主要由特定T细胞亚群，干细胞记忆或TSCM组成的候选产品，目标是补偿CAR-T疗法的局限性，包括治疗持续时间，治疗能力实体瘤和耐受性问题。该公司相信，该公司的管理团队在细胞和基因工程方面的经验将帮助快速发展，并希望获得将潜在的治疗性细胞和基因疗法商业化的批准。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.036565},{"month":2,"riseRate":0.5,"avgChangeRate":0.00152},{"month":3,"riseRate":0.25,"avgChangeRate":-0.140178},{"month":4,"riseRate":0,"avgChangeRate":-0.1786},{"month":5,"riseRate":0.25,"avgChangeRate":-0.066802},{"month":6,"riseRate":0.5,"avgChangeRate":0.01857},{"month":7,"riseRate":0.25,"avgChangeRate":-0.008411},{"month":8,"riseRate":0.6,"avgChangeRate":0.027276},{"month":9,"riseRate":0.4,"avgChangeRate":-0.001281},{"month":10,"riseRate":0.4,"avgChangeRate":0.003161},{"month":11,"riseRate":1,"avgChangeRate":0.691036},{"month":12,"riseRate":0.6,"avgChangeRate":0.075318}],"exchange":"NASDAQ","name":"Poseida Therapeutics, Inc.","nameEN":"Poseida Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Poseida Therapeutics, Inc.(PSTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Poseida Therapeutics, Inc.(PSTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Poseida Therapeutics, Inc.,PSTX,Poseida Therapeutics, Inc.股票,Poseida Therapeutics, Inc.股票老虎,Poseida Therapeutics, Inc.股票老虎国际,Poseida Therapeutics, Inc.行情,Poseida Therapeutics, Inc.股票行情,Poseida Therapeutics, Inc.股价,Poseida Therapeutics, Inc.股市,Poseida Therapeutics, Inc.股票价格,Poseida Therapeutics, Inc.股票交易,Poseida Therapeutics, Inc.股票购买,Poseida Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Poseida Therapeutics, Inc.(PSTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Poseida Therapeutics, Inc.(PSTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}